Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses.
Glintborg B, Lindström U, Giuseppe DD, Provan SA, Gudbjornsson B, Hetland ML, Michelsen B, Wallman JK, Aaltonen K, Hokkanen AM, Nordström D, Jørgensen TS, Hansen RL, Geirsson AJ, Grøn KL, Krogh NS, Askling J, Kristensen LE, Jacobsson LTH; Danish Rheumatology Database (DANBIO), Anti-Rheumatic Therapy in Sweden/Swedish Rheumatology Quality (ARTIS/SRQ), Center for Rheumatology Research (ICEBIO), Finnish Register of Biological Treatment (ROB-FIN), and Norwegian Antirheumatic Drug Register (NOR-DMARD) registries. Glintborg B, et al. Among authors: provan sa. Arthritis Care Res (Hoboken). 2022 May;74(5):748-758. doi: 10.1002/acr.24523. Epub 2022 Mar 8. Arthritis Care Res (Hoboken). 2022. PMID: 33253491
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.
Chatzidionysiou K, Hetland ML, Frisell T, Di Giuseppe D, Hellgren K, Glintborg B, Nordström D, Aaltonen K, Törmänen MR, Klami Kristianslund E, Kvien TK, Provan SA, Björn Guðbjörnsson B, Dreyer L, Kristensen LE, Jørgensen TS, Jacobsson L, Askling J. Chatzidionysiou K, et al. Among authors: provan sa. RMD Open. 2018 Apr 12;4(1):e000655. doi: 10.1136/rmdopen-2018-000655. eCollection 2018. RMD Open. 2018. PMID: 29682328 Free PMC article. Review.
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Lund Hansen R, Schoedt Jørgensen T, Dreyer L, Hetland ML, Glintborg B, Askling J, Di Giuseppe D, Jacobsson LTH, Wallman JK, Nordstrom D, Aaltonen K, Kristianslund EK, Kvien TK, Provan SA, Gudbjornsson B, Love TJ, Kristensen LE. Lund Hansen R, et al. Among authors: provan sa. Rheumatology (Oxford). 2021 Jan 5;60(1):140-146. doi: 10.1093/rheumatology/keaa237. Rheumatology (Oxford). 2021. PMID: 32591790
How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers.
Chatzidionysiou K, Delcoigne B, Frisell T, Hetland ML, Glintborg B, Dreyer L, Cordtz R, Zobbe K, Nordström D, Trokovic N, Aaltonen K, Provan SA, Grondal G, Gudbjornsson B, Askling J. Chatzidionysiou K, et al. Among authors: provan sa. RMD Open. 2020 Sep;6(2):e001363. doi: 10.1136/rmdopen-2020-001363. RMD Open. 2020. PMID: 32900882 Free PMC article. No abstract available.
Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis.
Hammer HB, Michelsen B, Sexton J, Uhlig T, Provan SA. Hammer HB, et al. Among authors: provan sa. Clin Rheumatol. 2021 May;40(5):1739-1749. doi: 10.1007/s10067-020-05402-y. Epub 2020 Oct 11. Clin Rheumatol. 2021. PMID: 33040226 Free PMC article.
80 results